Request Appointment
160 East 53rd StreetNew York, NY 10022
Overview of Dr. Grommes
Dr. Christian Grommes is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, New York-Presbyterian Hospital, and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from RWTH Aachen University FOM and has been in practice 26 years. Dr. Grommes accepts several types of health insurance, listed below. He is one of 397 doctors at New York-Presbyterian Hospital and one of 527 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He also speaks multiple languages, including German. He has more than 90 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Neuro-Oncology, 2009 - 2011
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Neurology, 2006 - 2009- Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Internal Medicine, 2005 - 2006
- University Hospitals Cleveland Medical CenterPost-Doctoral Fellowship, 2002 - 2005
University of BonnResidency, Neurology, 2000 - 2002
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2009 - 2028
NJ State Medical License 2023 - 2027
OH State Medical License 2005 - 2027
PA State Medical License 2022 - 2026
VA State Medical License 2021 - 2026
American Board of Psychiatry and Neurology Neurology
United Council for Neurologic SubspecialtiesNeuro-Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2016-2017
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
Clinical Trials
- Copanlisib With Ibrutinib for Patients With Recurrent/ Refractory Primary Central Nervous System Lymphoma (PCNSL) Start of enrollment: 2018 Aug 23
- LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma Start of enrollment: 2018 Nov 14
- Ibrutinib With Rituximab and Lenalidomide for Patients With Recurrent/Refractory Primary or Secondary Central Nervous System Lymphoma (PCNSL/SCNSL) Start of enrollment: 2019 Jan 22
Publications & Presentations
PubMed
- Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine for newly diagnosed primary CNS lymphoma.Lauren R Schaff, Elena Pentsova, Rachna Malani, Jacqueline Stone, Igor T Gavrilovic
Neuro-Oncology. 2026-05-01 - Outcomes of inpatient chemoradiotherapy for patients with newly diagnosed glioblastoma and significant functional impairment.Neil Sielski, Anne S Reiner, William E Rosa, Brandon S Imber, Luke R G Pike
Neuro-Oncology Practice. 2026-04-01 - 2 citationsMulticenter randomized phase II study of R-MPV-A chemoimmunotherapy with or without low-dose whole-brain radiotherapy for newly-diagnosed primary CNS lymphoma.Antonio Omuro, Lisa M DeAngelis, Mei-Yin C Polley, Denise Correa, Jeffrey S Wefel
Neuro-Oncology. 2026-02-01
Journal Articles
- Phase I Study of Pomalidomide and Dexamethasone for relapsed/refractory Primary CNS or Vitreo-Retinal LymphomaLisa M DeAngelis, Han W Tun, David Schiff, Kurt A Jaeckle, Christian Grommes, Patrick B Johnston, Craig B Reeder, Thomas E Witzig, Blood
Professional Memberships
- Member
- Member
- Member
- Society of Neuro-OncologyMember
Other Languages
- German
External Links
- MSKCChttps://www.mskcc.org/cancer-care/doctors/christian-grommes
Insurance Accepted
- BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPOGreat West PPO
Humana ChoiceCare Network PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
